Evidence map›Paper›PMID 22970186›Full record

ArticlePloS one2012

Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features.

Jesús Rodríguez-Baño, Jesús Mingorance, Natalia Fernández-Romero, Lara Serrano, Lorena López-Cerero, Alvaro Pascual, ESBL-REIPI Group

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Molecular Characterization of High and Low VirulentInfection and drug resistance · 2024
    Article
  3. Article
  4. Molecular epidemiology of blaAnnals of clinical microbiology and antimicrobials · 2021
    Article
  5. Pathogenesis of Gram-Negative Bacteremia.Clinical microbiology reviews · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jesús Rodríguez-BañoUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain. jesusrb@us.es
Jesús Mingorance
Natalia Fernández-Romero
Lara Serrano
Lorena López-Cerero
Alvaro Pascual
ESBL-REIPI Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is scarce data about the importance of phylogroups and virulence factors (VF) in bloodstream infections (BSI) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBLEC). A prospective multicenter Spanish cohort including 191 cases of BSI due to ESBLEC was studied. Phylogroups and 25 VF genes were investigated by PCR. ESBLEC were classified into clusters according to their virulence profiles. The association of phylogropus, VF, and clusters with epidemiological features were studied using multivariate analysis. Overall, 57.6%, 26.7%, and 15.7% of isolates belonged to A/B1, D and B2 phylogroups, respectively. By multivariate analysis (adjusted OR [95% CI]), virulence cluster C2 was independently associated with urinary tract source (5.05 [0.96-25.48]); cluster C4 with sources other than urinary of biliary tract (2.89 [1.05-7.93]), and cluster C5 with BSI in non-predisposed patients (2.80 [0.99-7.93]). Isolates producing CTX-M-9 group ESBLs and from phylogroup D predominated among cluster C2 and C5, while CTX-M-1 group of ESBL and phylogroup B2 predominantes among C4 isolates. These results suggest that host factors and previous antimicrobial use were more important than phylogroup or specific VF in the occurrence of BSI due to ESBLEC. However, some associations between virulence clusters and some specific epidemiological features were found.

Indexed as

AgedAged, 80 and overAnti-Infective AgentsBacteremiabeta-LactamasesDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsFemaleGenes, BacterialHumansMaleMicrobial Sensitivity TestsMiddle AgedMultigene FamilyMultivariate AnalysisAnti-Infective Agentsbeta-LactamasesVirulence Factors

Identifiers

PMID22970186
PMCPMC3436869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.